Compare BNTX & ASTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BNTX | ASTS |
|---|---|---|
| Founded | 2008 | 2019 |
| Country | Germany | United States |
| Employees | N/A | 1126 |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Telecommunications Equipment |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 24.2B | 25.4B |
| IPO Year | 2019 | N/A |
| Metric | BNTX | ASTS |
|---|---|---|
| Price | $92.83 | $76.82 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 13 | 8 |
| Target Price | ★ $133.46 | $72.10 |
| AVG Volume (30 Days) | 966.0K | ★ 20.9M |
| Earning Date | 05-05-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $167.10 |
| Revenue Next Year | $3.37 | $391.80 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $79.81 | $39.50 |
| 52 Week High | $124.00 | $133.86 |
| Indicator | BNTX | ASTS |
|---|---|---|
| Relative Strength Index (RSI) | 51.99 | 44.78 |
| Support Level | $90.95 | $67.12 |
| Resistance Level | $94.20 | $100.41 |
| Average True Range (ATR) | 2.24 | 7.23 |
| MACD | 0.50 | 0.01 |
| Stochastic Oscillator | 42.61 | 46.63 |
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including covid. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens and neoantigens; monospecific and bispecific antibodies; and antibody-drug conjugates, or ADCs. Comirnaty, its Pfizer-partnered covid vaccine, is its first commercialized product.
AST SpaceMobile Inc is currently designing, developing and manufacturing the constellation of BlueBird (BB) satellites and has begun launching its planned space-based Cellular Broadband network distributed through a constellation of low Earth orbit (LEO) satellites. The company is building a cellular broadband network in space to operate directly with standard, unmodified mobile devices, and off-the-shelf mobile phones based on extensive IP and patent portfolio. It has focused on eliminating the connectivity gaps faced by mobile subscribers. The Company's spaceMobile Service is being designed to provide cost-effective, high-speed Cellular Broadband services to end-users who are out of terrestrial cellular coverage using existing mobile devices.